565 related articles for article (PubMed ID: 17018493)
1. Factor VIIa in puerperal hemorrhage with disseminated intravascular coagulation.
Pepas LP; Arif-Adib M; Kadir RA
Obstet Gynecol; 2006 Sep; 108(3 Pt 2):757-61. PubMed ID: 17018493
[TBL] [Abstract][Full Text] [Related]
2. Treatment of obstetric hemorrhage with recombinant activated factor VII (rFVIIa).
Segal S; Shemesh IY; Blumenthal R; Yoffe B; Laufer N; Ezra Y; Levy I; Mazor M; Martinowitz U
Arch Gynecol Obstet; 2003 Oct; 268(4):266-7. PubMed ID: 14504866
[TBL] [Abstract][Full Text] [Related]
3. Recombinant factor VIIa to successfully manage disseminated intravascular coagulation from amniotic fluid embolism.
Prosper SC; Goudge CS; Lupo VR
Obstet Gynecol; 2007 Feb; 109(2 Pt2):524-5. PubMed ID: 17267882
[TBL] [Abstract][Full Text] [Related]
4. Single-center experience: use of recombinant factor VIIa for acute life-threatening bleeding in children without congenital hemorrhagic disorder.
Yilmaz D; Karapinar B; Balkan C; Akisü M; Kavakli K
Pediatr Hematol Oncol; 2008 Jun; 25(4):301-11. PubMed ID: 18484474
[TBL] [Abstract][Full Text] [Related]
5. Recombinant factor VIIa in the management of postpartum bleeds: an audit of clinical use.
Sobieszczyk S; Breborowicz GH; Platicanov V; Tanchev S; Kessler CM
Acta Obstet Gynecol Scand; 2006; 85(10):1239-47. PubMed ID: 17068684
[TBL] [Abstract][Full Text] [Related]
6. [The use of recombinant factor VIIa on the therapy of massive bleeding after cesarean section].
Uharcek P; Mlyncek M; Kellner M; Lajtman E
Ceska Gynekol; 2007 May; 72(3):200-2. PubMed ID: 17616074
[TBL] [Abstract][Full Text] [Related]
7. Successful management by recombinant activated factor VII in a case of disseminated intravascular coagulopathy caused by obstetric hemorrhage.
Nohira T; Osakabe Y; Suda S; Takahashi C; Tanaka A; Ikeda K; Ikeda T; Okabe K
J Obstet Gynaecol Res; 2008 Aug; 34(4 Pt 2):623-30. PubMed ID: 18840167
[TBL] [Abstract][Full Text] [Related]
8. Recombinant factor VIIa after amniotic fluid embolism and disseminated intravascular coagulopathy.
Lim Y; Loo CC; Chia V; Fun W
Int J Gynaecol Obstet; 2004 Nov; 87(2):178-9. PubMed ID: 15491576
[TBL] [Abstract][Full Text] [Related]
9. [Successful application of recombinant activated factor VII in a patient with HELLP syndrome and disseminated intravascular coagulation].
Ilić-Mostić T; Argirović R; Sparić R; Ljubić A; Bozanović T; Jeremić K; Tomanović-Koković J; Kadija S
Srp Arh Celok Lek; 2008 Sep; 136 Suppl 3():253-8. PubMed ID: 19562879
[TBL] [Abstract][Full Text] [Related]
10. Recombinant activated Factor VII as a hemostatic agent in very low birth weight preterms with gastrointestinal hemorrhage and disseminated intravascular coagulation.
Fischer D; Schloesser R; Buxmann H; Veldman A
J Pediatr Hematol Oncol; 2008 May; 30(5):337-42. PubMed ID: 18458565
[TBL] [Abstract][Full Text] [Related]
11. Potential role of recombinant activated factor VII for the treatment of severe bleeding associated with disseminated intravascular coagulation: a systematic review.
Franchini M; Manzato F; Salvagno GL; Lippi G
Blood Coagul Fibrinolysis; 2007 Oct; 18(7):589-93. PubMed ID: 17890943
[TBL] [Abstract][Full Text] [Related]
12. A critical review on the use of recombinant factor VIIa in life-threatening obstetric postpartum hemorrhage.
Franchini M; Franchi M; Bergamini V; Salvagno GL; Montagnana M; Lippi G
Semin Thromb Hemost; 2008 Feb; 34(1):104-12. PubMed ID: 18393147
[TBL] [Abstract][Full Text] [Related]
13. Postpartum hemorrhage: when uterotonics and sutures fail.
James AH; McLintock C; Lockhart E
Am J Hematol; 2012 May; 87 Suppl 1():S16-22. PubMed ID: 22430921
[TBL] [Abstract][Full Text] [Related]
14. Caesarean section for placenta praevia complicated by postpartum haemorrhage managed successfully with recombinant activated human coagulation Factor VIIa.
Gidiri M; Noble W; Rafique Z; Patil K; Lindow SW
J Obstet Gynaecol; 2004 Nov; 24(8):925-6. PubMed ID: 16147656
[No Abstract] [Full Text] [Related]
15. Effectiveness of recombinant activated factor VII (rFVII a) for controlling intractable postpartum bleeding: report of two cases and literature review.
Jirapinyo M; Manonai J; Herabutya Y; Chuncharunee S
J Med Assoc Thai; 2007 May; 90(5):977-81. PubMed ID: 17596055
[TBL] [Abstract][Full Text] [Related]
16. Recombinant factor VIIa: safety and efficacy.
Goodnough LT; Shander AS
Curr Opin Hematol; 2007 Sep; 14(5):504-9. PubMed ID: 17934358
[TBL] [Abstract][Full Text] [Related]
17. The use of recombinant factor VIIa in severe postpartum hemorrhage.
Segal S; Shemesh IY; Blumental R; Yoffe B; Laufer N; Mankuta D; Mazor M; Zohar S; Schiff E; Martinovitz U
Acta Obstet Gynecol Scand; 2004 Aug; 83(8):771-2. PubMed ID: 15255852
[No Abstract] [Full Text] [Related]
18. The use of recombinant activated factor VII in the treatment of massive pulmonary hemorrhage in a preterm infant.
Cetin H; Yalaz M; Akisu M; Karapinar DY; Kavakli K; Kultursay N
Blood Coagul Fibrinolysis; 2006 Apr; 17(3):213-6. PubMed ID: 16575260
[TBL] [Abstract][Full Text] [Related]
19. Guidelines for use of recombinant factor VIIa in life-threatening post-partum haemorrhage.
Duffy MR
Int J Obstet Anesth; 2007 Jul; 16(3):299-300; author reply 300. PubMed ID: 17509865
[No Abstract] [Full Text] [Related]
20. Failure of recombinant factor VIIa to correct the coagulopathy in a case of severe postpartum hemorrhage.
Lewis NR; Brunker P; Lemire SJ; Kaufman RM
Transfusion; 2009 Apr; 49(4):689-95. PubMed ID: 19347977
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
